Cel-Sci Corp (CVM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CVM | ONCY | SPRO | ||
| Company | Cel-Sci Corp | Oncolytics Biotech Inc | Spero Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NYSE Arca | NASDAQ | NASDAQ | ||
| Open | 1.5000 | 1.1900 | 1.6300 | ||
| High | 1.7300 | 1.1900 | 1.6494 | ||
| Low | 1.4900 | 1.1600 | 1.6200 | ||
| Last | 1.6300 | 1.1700 | 1.6300 | ||
| Change | +0.1500 | unch | +0.0200 | ||
| % Change | +10.14% | unch | +1.24% | ||
| Volume | 382,300 | 98,100 | 92,800 | ||
| 20-Day Average Volume | 172,245 | 190,835 | 198,345 | ||
| Previous Close | 1.4800 | 1.1700 | 1.6100 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 1.5425 | 1.1000 | 1.5293 | ||
| 20-Day Raw Stochastic | 52.17% | 84.21% | 68.42% | ||
| 20-Day Relative Strength | 45.73% | 58.41% | 54.02% | ||
| Weighted Alpha | -53.24 | -42.04 | -4.20 | ||
| Today's Opinion | 72% Sell | 24% Sell | 40% Buy | ||
| Previous Opinion | 88% Sell | 24% Sell | 40% Buy | ||
| Last Month's Opinion | 56% Sell | 64% Sell | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +13.19% since 04/26/24 | +7.34% since 04/26/24 | +11.64% since 04/26/24 | ||
| Low | 1.3900 on 04/29/24 | 1.0800 on 05/01/24 | 1.4200 on 04/30/24 | ||
| High | 1.7300 on 05/03/24 | 1.1900 on 05/03/24 | 1.6700 on 05/02/24 | ||
| 1-Month | |||||
| %Chg | -11.89% since 04/03/24 | +6.36% since 04/03/24 | -8.94% since 04/03/24 | ||
| Low | 1.3900 on 04/29/24 | 1.0100 on 04/16/24 | 1.3700 on 04/22/24 | ||
| High | 1.8790 on 04/04/24 | 1.2900 on 04/04/24 | 1.8000 on 04/04/24 | ||
| 3-Month | |||||
| %Chg | -42.20% since 02/02/24 | +1.74% since 02/02/24 | +12.03% since 02/02/24 | ||
| Low | 1.3900 on 04/29/24 | 0.8830 on 02/07/24 | 1.3300 on 02/08/24 | ||
| High | 3.0800 on 02/06/24 | 1.2900 on 04/04/24 | 1.8900 on 03/14/24 | ||
| 6-Month | |||||
| %Chg | -18.50% since 11/03/23 | -31.98% since 11/03/23 | +36.97% since 11/03/23 | ||
| Low | 1.3900 on 04/29/24 | 0.8830 on 02/07/24 | 1.0400 on 11/09/23 | ||
| High | 3.2300 on 12/27/23 | 1.7500 on 11/27/23 | 1.8900 on 03/14/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 87,986 | 88,241 | 87,846 | ||
| Shares Outstanding, K | 53,979 | 75,420 | 53,893 | ||
| Annual Sales | 0 | 0 | 103,780,000 | ||
| Annual Net Income | -32,190,000 | -20,560,000 | 22,810,000 | ||
| Last Quarter Sales | 0 | 0 | 73,520,000 | ||
| Last Quarter Net Income | -6,710,000 | -2,870,000 | 51,190,000 | ||
| 60-Month Beta | 1.23 | 1.91 | 0.62 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.14 on 02/14/24 | -0.04 on 03/07/24 | 0.96 on 03/13/24 | ||
| Latest Earnings Date | 05/10/24 | 05/09/24 | 05/09/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | 09/16/15 | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 3.22 | ||